| Literature DB >> 28424090 |
Christina Unterberg-Buchwald1,2,3, Christian Oliver Ritter4,5, Verena Reupke6, Robin Niklas Wilke4,5, Christine Stadelmann7, Michael Steinmetz4,8, Andreas Schuster9,4, Gerd Hasenfuß9,4, Joachim Lotz4,5, Martin Uecker4,5.
Abstract
BACKGROUND: Endomyocardial biopsies (EMB) are an important diagnostic tool for myocarditis and other infiltrative cardiac diseases. Routinely, biopsies are obtained under fluoroscopic guidance with a substantial radiation burden. Despite procedural success, there is a large sampling error caused by missing the affected myocardium. Therefore, multiple (>6) biopsies are taken in the clinical setting. In cardiovascular magnetic resonance (CMR), late gadolinium enhancement (LGE) depicts areas of affected myocardium in myocarditis or in other infiltrative cardiomyopathies. Thus, targeted biopsy under real-time CMR image guidance might reduce the problem of sampling error.Entities:
Keywords: CMR; Endomyocardial biopsy; Real-time MRI; Targeted biopsy
Mesh:
Year: 2017 PMID: 28424090 PMCID: PMC5395773 DOI: 10.1186/s12968-017-0357-3
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Fig. 1Bioptomes. Bioptomes with forceps in the open state: the two bioptomes on the left are MR-conditional, the one on the right hand is a standard steel bioptome employed for EMB under fluoroscopic guidance. Notably, the standard bioptome achieves a maximum opening angle of about 90° whereas the MR-bioptomes only open at a maximum angle of about 50–70°
Numbers and pathologic findings in targeted endomyocardial biopsies gained under RT-CMR or fluoroscopic guidance (Fl)
| Ablation sites | No. of EMB RT-CMR/No. of trials | No. of EMB Fl/No. of trials | No. of positive samples | Pathology correctly diagnosed/minipig | Lesion size | |||
|---|---|---|---|---|---|---|---|---|
| RT-CMR | Fl | RT -CMR | Fl | [g] | [% total LV mass] | |||
| 3 | 3/6 | 0/0 | 3 | 0 | yes | no | 3.1 | 8.5 |
| 2 | 4/4 | 4/4 | 1 | 0 | yes | no | 12.8 | 22.8 |
| 3 | 2/6 | 1/1 | 1 | 0 | yes | no | 6.0 | 11 |
| 2 | 2/6 | 3/3 | 0 | 1 | no | yes | 11.4 | 20.6 |
| 3 | 0/5 | 2/2 | 0 | 0 | no | no | 3.5 | 7.7 |
| 3 | 4/6 | 3/3 | 2 | 1 | yes | yes | 2.7 | 5.0 |
| 3 | 0/0 | 4/4 | 0 | 2 | no | yes | Not done | |
Number (No) of tissue samples obtained by endomyocardial biopsy (EMB) under real-time CMR and under fluoroscopy (Fl), number of trials of biopsies and lesion size in g and in % of total left ventricular (LV) mass are given. No EMB trials were done in the first animal under FL and in the last animal due to large pericardial effusion
Fig. 2a: Postcontrast visualization and assessment of acute lesions. Postcontrast two-dimensional PSIR-LGE (2D LGE) in two different animals after radiofrequency ablation. LGE images show good contrast between the lesion with its edematous core and the myocardium (white arrow). a: lesions targeted for biopsy are shown in an infero-basal segment in a long axis view and b: in a short axis view with c: the markers for quantitative segmentation of the lesion area (red area, see methods)
Fig. 3Guidewire, guiding catheter and MR-bioptome visualized by real-time CMR pre biopsy. The instruments with MR-markers are visualized by interactive real-time CMR during a targeted biopsy. a: The guidewire (blue arrow with square end) and the guiding catheter (yellow arrow with square end) are advanced into the left ventricle through the aorta. b: The MR-conditional bioptome is used to perform a biopsy (violet arrow with round end) c and d: The bioptome (violet arrow with round end) is advanced inside (c) and then extruded out of (d) the guiding catheter (yellow arrow with square end)
Fig. 4Histology of endomyocardial biopsies. HE staining a: The endomyocardial biopsy shows regular myocardium. This specimen was gained under fluoroscopic guidance in minipig 1 (see Table 1). b: One of the two specimens obtained under CMR guidance. The ablated area reveals areas of myocardial coagulation with extensive hemorrhage